Phillip Dolamore
Keine laufenden Positionen mehr
Karriereverlauf von Phillip Dolamore
Ehemalige bekannte Positionen von Phillip Dolamore
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Glaxo, Inc. | Corporate Officer/Principal | - | - |
| GlaxoWellcome /Pharmocology Unit/ | Corporate Officer/Principal | - | - |
GlycoForm Ltd.
 GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Corporate Officer/Principal | 01.01.2008 | - |
Statistik
International
| Vereinigtes Königreich | 3 |
| Kanada | 2 |
Operativ
| Corporate Officer/Principal | 3 |
Sektoral
| Health Technology | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
GlycoForm Ltd.
GlycoForm Ltd. Pharmaceuticals: MajorHealth Technology Glycoform Ltd. develops pharmaceutical products. The firm's novel synthetic glycoprotein, GLY510, is designed for the treatment of anemia. It provides services in the areas of therapeutic proteins, drug targeting using glycosylation, and enzyme activated pro-drug technology. The company was founded by Benjamin G. Davis and Antony J. Fairbanks in November 2002 and is headquartered in Abingdon, UK | Health Technology |
| Glaxo, Inc. | |
| GlaxoWellcome /Pharmocology Unit/ | Commercial Services |
- Börse
- Insiders
- Phillip Dolamore
- Erfahrung
